Jason Pitofsky sold $1.4M of Regeneron Pharmaceuticals (REGN)

Executed Feb 9, disclosed Feb 11, 2 days later.

Value, as filed

$1.4M

1,824 sh across 5 lots

Executed

Feb 9

the trade date, as filed

Disclosed

Feb 11

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason Pitofsky VP Controller profile →

Jason Pitofsky (VP Controller) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $3.8M of REGN (4,027 sh across 7 lots, as filed), executed Nov 4.

The name

REGN

Regeneron Pharmaceuticals, Inc. REGN · Healthcare · 35 filings in 24 months ticker →

Healthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason Pitofsky in REGN

REGNSALE Regeneron Pharmaceuticals, Inc. $3.8M
4,027 sh across 7 lots
Exec Nov 4
Filed Nov 6 · 4:01 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. $281K
431 sh × $651.43
Exec Nov 7 2025
Filed Nov 10 2025 · 5:30 PM ET